Validation pour Ingenuity274

vers la météo de la validation par utilisateur

Ingenuity274

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 76 - PMID ?

In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of SP NODE that is increased by NODE .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                                   
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 1

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                                   
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 2

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 3

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 4

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 5

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 6

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 7

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 8

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 9

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 10

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                                   
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 11

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                                   
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 12

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 13

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 14

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 15

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 16

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 17

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 18

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 19

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 20

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 21

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 22

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 23

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 24

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 25

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 26

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 27

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |                      +---------OBJ:V-N--------+                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 28

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+                  
                |                     |                             +COMP:N-N(o+        |                      |       +----SUBJ:V-N----+                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 29

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 30

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |                      +---------OBJ:V-N--------+                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 31

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |                      |       +----SUBJ:V-N----+                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 32

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |          +---------------OBJ:V-N--------------+                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 33

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+                  
                |                     |                             +COMP:N-N(o+        |          |                   +----SUBJ:V-N----+                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 34

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +---------------OBJ:V-N--------------+                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 35

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          |                   +----SUBJ:V-N----+                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 36

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 37

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 38

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 39

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 40

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |                             +COMP:N-N(o+        |                      +---------OBJ:V-N--------+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 41

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
                |                     |                             +COMP:N-N(o+        |                      |       +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 42

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 43

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 44

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 45

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |                      +---------OBJ:V-N--------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 46

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |                      |       +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 47

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 48

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |                             +COMP:N-N(o+        |          +---------------OBJ:V-N--------------+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 49

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
                |                     |                             +COMP:N-N(o+        |          |                   +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 50

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +---------------OBJ:V-N--------------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 51

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          |                   +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 52

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 53

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 54

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 55

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 56

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 57

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+          |     +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 58

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 59

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+          |     +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 60

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 61

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 62

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 63

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 64

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 65

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
                +--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+          |     +MOD:V-+     |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 66

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 67

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        |          |           +MOD_ATT+          |     +MOD:V-+     |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 68

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                                   
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 69

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 70

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                                   
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 71

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 72

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 73

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 74

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 75

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 76

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 77

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 78

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |                             +COMP:N-N(o+        |          |           +---------OBJ:V-N--------+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 79

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          |           +---------OBJ:V-N--------+            |     
                |                     |                             +COMP:N-N(o+        |          |           |       +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 80

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 81

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 82

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          |           +---------OBJ:V-N--------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 83

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          |           +---------OBJ:V-N--------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          |           |       +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 84

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 85

                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+          |     +COMP:V_PASS-+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 86

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 87

                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+          |     +COMP:V_PASS-+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 88

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 89

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 90

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 91

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 92

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 93

                                                                                        +------------------------COMP:V-N(by)------------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 94

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 95

                                                                                        +------------------------COMP:V-N(by)------------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 96

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 97

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 98

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 99

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 100

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 101

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+          |     |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 102

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 103

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+          |     |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 104

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 105

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 106

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 107

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 108

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 109

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
                +--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+          |     |                  
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 110

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 111

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
     +MOD_ATT:N-+--------APPOS--------+                             +COMP:N-N(o+                   +----COMP:N-N(of)---+          |     |                  
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 112

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 113

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                              +---------COMP:N-N(by)--------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 114

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 115

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                              +---------COMP:N-N(by)--------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 116

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 117

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |                      +---------OBJ:V-N--------+                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 118

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+                  
                |                     |           +-----------OBJ:V-N----------+        |                      |       +----SUBJ:V-N----+                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 119

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 120

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 121

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 122

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |                      +---------OBJ:V-N--------+                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 123

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |                      |       +----SUBJ:V-N----+                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 124

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 125

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 126

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |          +---------------OBJ:V-N--------------+                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 127

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+                  
                |                     |           +-----------OBJ:V-N----------+        |          |                   +----SUBJ:V-N----+                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 128

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +---------------OBJ:V-N--------------+                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 129

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          |                   +----SUBJ:V-N----+                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)
COMP:V-N(by) (increase,__NODE__)

Analyse 130

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 131

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 132

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |           +-----------OBJ:V-N----------+        |                      +---------OBJ:V-N--------+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 133

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
                |                     |           +-----------OBJ:V-N----------+        |                      |       +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 134

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 135

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,expression)

Analyse 136

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 137

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |                      +---------OBJ:V-N--------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 138

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |                      |       +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 139

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 140

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 141

                                                                                                   +-------------------COMP:N-N(by)------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
                |                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 142

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 143

                                                                                                   +-------------------COMP:N-N(by)------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 144

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +---------------OBJ:V-N--------------+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 145

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          |                   +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 146

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +---------------OBJ:V-N--------------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 147

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          |                   +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 148

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 149

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 150

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 151

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 152

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 153

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+          |     +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 154

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 155

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+          |     +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 156

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 157

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 158

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 159

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+-SUBJ:V-N-+     +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 160

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 161

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
                +--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+          |     +MOD:V-+     |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 162

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+                +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 163

                +------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------+     
                |                                                                       +--------------------------SUBJ:V-N--------------------------+     
                |                                                                       +--------------------OBJ:V-N--------------------+            |     
                |                                                                       |          +--------------SUBJ:V-N--------------+            |     
                |                                                                       |          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        |          |           +MOD_ATT+          |     +MOD:V-+     |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |      |     |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD:V-ADV (increase,by)
COMP:V-N(In) (__NODE__,cell)
SUBJ:V-N (__NODE__,decrease)

Analyse 164

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                                   
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 165

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 166

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                                   
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 167

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 168

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +-------------COMP:N-N(by)------------+     
                |                     |                             +COMP:N-N(o+        |                      +---------OBJ:V-N--------+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 169

                +------------------------------COMP:V-N(In)-----------------------------+                      +-------------COMP:N-N(by)------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
                |                     |                             +COMP:N-N(o+        |                      |       +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 170

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +-------------COMP:N-N(by)------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |                      +---------OBJ:V-N--------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 171

                +------------------------------COMP:V-N(In)-----------------------------+                      +-------------COMP:N-N(by)------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |                      |       +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 172

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 173

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 174

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          |           +---------OBJ:V-N--------+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 175

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          |           +---------OBJ:V-N--------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          |           |       +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 176

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |                             +COMP:N-N(o+        |          +---------------OBJ:V-N--------------+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 177

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
                |                     |                             +COMP:N-N(o+        |          |                   +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 178

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 179

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+------------------------COMP:V-N(by)------------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 180

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          |           +---------OBJ:V-N--------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 181

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          |           +---------OBJ:V-N--------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          |           |       +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 182

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 183

                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+          |     +COMP:V_PASS-+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 184

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          +---------------OBJ:V-N--------------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 185

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
     +MOD_ATT:N-+                     |                             +COMP:N-N(o+        |          |                   +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+                    +MOD_ATT:+      +MOD+        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |                    |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 186

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                +COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 187

                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+                  
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+          |     +COMP:V_PASS-+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)
COMP:V_PASS-N(by) (increase,__NODE__)

Analyse 188

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 189

                                                                                        +------------------------COMP:V-N(by)------------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 190

                +------------------------------COMP:V-N(In)-----------------------------+------------------------COMP:V-N(by)------------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 191

                                                                                        +------------------------COMP:V-N(by)------------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,__NODE__)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 192

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 193

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 194

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 195

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 196

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 197

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+          |     |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 198

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 199

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+          |     |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 200

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 201

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 202

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 203

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 204

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 205

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
                +--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+          |     |                  
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 206

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+                |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+                +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 207

                +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                  
                |                                                                                  +--------------SUBJ:V-N--------------+                  
                |                                                                                  +-----------SUBJ:V-N-----------+     |                  
     +MOD_ATT:N-+--------APPOS--------+           +-----------OBJ:V-N----------+                   +----COMP:N-N(of)---+          |     |                  
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +MOD_ATT:N-+           +MOD_ATT+          |     +COMP:V-N(by)+     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
APPOS (cell,deoxycytidine)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__NODE__)

Analyse 208

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 209

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                              +---------COMP:N-N(by)--------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 210

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                                                                  
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+---------COMP:N-N(by)--------+     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 211

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                              +---------COMP:N-N(by)--------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 212

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 213

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 214

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                             |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+--SUBJ:V_PASS-N-+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 215

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+--SUBJ:V_PASS-N-+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,__NODE__)
SUBJ:V_PASS-N (increase,__NODE__)

Analyse 216

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 217

                                                                                                   +-------------------COMP:N-N(by)------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
                |                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 218

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +------------SUBJ:V_PASS-N-----------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+                |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+                |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V_PASS-N (increase,expression)

Analyse 219

                                                                                                   +-------------------COMP:N-N(by)------------------+     
                +------------------------------COMP:V-N(In)-----------------------------+          +------------SUBJ:V_PASS-N-----------+            |     
                |                     +---------------------SUBJ:V-N--------------------+          +-----------SUBJ:V-N-----------+     |            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +----COMP:N-N(of)---+          |     |            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+           +MOD_ATT+          |     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (increase,expression)

Analyse 220

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +-------------COMP:N-N(by)------------+     
                |                     |           +-----------OBJ:V-N----------+        |                      +---------OBJ:V-N--------+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 221

                +------------------------------COMP:V-N(In)-----------------------------+                      +-------------COMP:N-N(by)------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
                |                     |           +-----------OBJ:V-N----------+        |                      |       +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 222

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+                      +-------------COMP:N-N(by)------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |                      +---------OBJ:V-N--------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 223

                +------------------------------COMP:V-N(In)-----------------------------+                      +-------------COMP:N-N(by)------------+     
                |                     +---------------------SUBJ:V-N--------------------+                      +---------OBJ:V-N--------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |                      |       +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,__SP__)
SUBJ:V-N (increase,__NODE__)

Analyse 224

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     |           +-----------OBJ:V-N----------+        |          +---------------OBJ:V-N--------------+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 225

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
                |                     |           +-----------OBJ:V-N----------+        |          |                   +----SUBJ:V-N----+            |     
          +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
          |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 226

                +------------------------------COMP:V-N(In)-----------------------------+                                                                  
                |                     +---------------------SUBJ:V-N--------------------+          +-------------------COMP:N-N(by)------------------+     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          +---------------OBJ:V-N--------------+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +----SUBJ:V-N----+            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |                |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)

Analyse 227

                +------------------------------COMP:V-N(In)-----------------------------+          +-------------------COMP:N-N(by)------------------+     
                |                     +---------------------SUBJ:V-N--------------------+          +---------------OBJ:V-N--------------+            |     
     +MOD_ATT:N-+                     |           +-----------OBJ:V-N----------+        |          |                   +----SUBJ:V-N----+            |     
     |    +MOD_A+        +-MOD_ATT:N-N+           |        +MOD_ATT:+COMP:N+   |        +--OBJ:V-N-+COMP:N-N(of+       +-SUBJ:V-N-+     |            |     
     |    |     |        |            |           |        |        |      |   |        |          |           |       |          |     |            |     
 In NCI H295r cells , 5 aza 2 ' deoxycytidine ( with a treatment period of 7 days ) decreases expression of __SP__ __NODE__ that is increased by __NODE__ .
MOD_ATT:N-N (cell,NCI)
MOD_ATT:N-N (cell,H295r)
MOD_ATT:N-N (deoxycytidine,aza)
OBJ:V-N (with,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,7)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,deoxycytidine)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,__NODE__)
SUBJ:V-N (be,__NODE__)
OBJ:V-N (increase,expression)
SUBJ:V-N (increase,__NODE__)